Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lee Schacter joins Clinipace

This article was originally published in Scrip

Executive Summary

Clinipace, a global digital contract research organization (dCRO), has named Dr Lee Schacter executive medical director, oncology. Dr Schacter will provide strategic guidance, program design, and medical oversight to clients conducting oncology development programs. Prior to joining Morrisville, North Carolina-based Clinipace, Dr Schacter was an independent consultant with Phasen Consulting, during which time he was CMO of the Multiple Myeloma Research Foundation, worked with Janssen R&D, and was medical director for marketed oncology products at AstraZeneca.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts